Birla Sun Life to launch first commodity-focussed fund
BSLAMC has decided to tap investors with its maiden commodity-centric fund, Birla Sun Life Commodity Equities Fund (BSLCEF), from September 15, a top company official said.
By PTI |
MUMBAI: Birla Sun Life Asset Management Company (BSLAMC) has decided to tap investors with its maiden commodity-centric fund, Birla Sun Life Commodity Equities Fund (BSLCEF), from September 15, a top company official said.
"The investment objective of BSLAMC's open-ended commodity equities fund is to offer investors long-term capital growth by investing in securities of domestic and overseas commodity companies, i.e. companies engaged in or focussing on the specified commodity business and overseas mutual fund schemes that have similar investment objectives," BSLAMC CEO Anil Kumar told reporters here today.
"We see commodities as essential and not an alternate investment class. Given that supply-side constraints and explosive demand are creating upward pressure on commodity prices, global commodity companies and commodity-focussed mutual funds are currently generating above par returns. We felt this is an opportune time to launch the BSLCEF to offer investors an avenue to diversify their portfolio," Kumar said.
Investors can enjoy the benefits of diversification by investing in Global Precious Metals Plan (benchmarked against Dow Jones Precious Metals Index), Global Agri Plan (benchmarked against S&P Global Agribusiness Index), and Global Multi Commodity Plan (benchmarked against MSCI World Index), he said.
Download
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
